메뉴 건너뛰기




Volumn 42, Issue 1, 2005, Pages 35-40

Outcomes associated with initiation of different controller therapies in a medicaid asthmatic population: A retrospective data analysis

Author keywords

Asthma; Claims data; Cost analyses; Inhaled corticosteroids; Leukotriene modifiers; Long acting agonists; Medicaid; Retrospective analysis

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; MONTELUKAST; SALMETEROL;

EID: 14944357686     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-200044769     Document Type: Article
Times cited : (20)

References (24)
  • 1
    • 0031001054 scopus 로고    scopus 로고
    • Potentially avoidable hospitalizations: Inequalities in rates between US socioeconomic groups
    • Pappas G, Hadden WC, Kozak LJ, Fisher GF. Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups. Am J Public Health 1997; 87(5):811-816.
    • (1997) Am J Public Health , vol.87 , Issue.5 , pp. 811-816
    • Pappas, G.1    Hadden, W.C.2    Kozak, L.J.3    Fisher, G.F.4
  • 2
    • 0025148981 scopus 로고
    • Changing patterns of asthma hospitalization among children: 1979 to 1987
    • Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among children: 1979 to 1987. JAMA 1990; 264(13):1688-1692.
    • (1990) JAMA , vol.264 , Issue.13 , pp. 1688-1692
    • Gergen, P.J.1    Weiss, K.B.2
  • 4
    • 0026540917 scopus 로고
    • Variations in asthma hospitalizations and deaths in New York City
    • Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health 1992; 82(1):59-65.
    • (1992) Am J Public Health , vol.82 , Issue.1 , pp. 59-65
    • Carr, W.1    Zeitel, L.2    Weiss, K.3
  • 5
    • 0029028941 scopus 로고
    • Use of health services by African-American children with asthma on Medicaid
    • Lozano P, Connell FA, Koepsell TD. Use of health services by African-American children with asthma on Medicaid. JAMA 1995; 274(6):469-473.
    • (1995) JAMA , vol.274 , Issue.6 , pp. 469-473
    • Lozano, P.1    Connell, F.A.2    Koepsell, T.D.3
  • 6
    • 0031902619 scopus 로고    scopus 로고
    • Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients
    • Balkrishnan R, Norwood GJ, Anderson A. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients. Clin Ther 1998; 20(3):567-580.
    • (1998) Clin Ther , vol.20 , Issue.3 , pp. 567-580
    • Balkrishnan, R.1    Norwood, G.J.2    Anderson, A.3
  • 7
    • 0002981074 scopus 로고    scopus 로고
    • Outcomes and cost benefit associated with introduction of inhaled corticosteroid therapy in a medicaid enrolled asthmatic children
    • Balkrishnan R, Norwood GJ, Anderson A. Outcomes and cost benefit associated with introduction of inhaled corticosteroid therapy in a medicaid enrolled asthmatic children. Drug Benefit Trends 1998; 10(10):37-40.
    • (1998) Drug Benefit Trends , vol.10 , Issue.10 , pp. 37-40
    • Balkrishnan, R.1    Norwood, G.J.2    Anderson, A.3
  • 8
    • 0012793107 scopus 로고    scopus 로고
    • Costs and utilization patterns associated with persistent asthma. A comparison of Texas Medicaid patients with and without continuous inhaled corticosteroid treatment
    • Smith MJ, Rascati KL, Johnsrud MT. Costs and utilization patterns associated with persistent asthma. A comparison of Texas Medicaid patients with and without continuous inhaled corticosteroid treatment. J Manag Care Pharm 2001; 7(6):452-459.
    • (2001) J Manag Care Pharm , vol.7 , Issue.6 , pp. 452-459
    • Smith, M.J.1    Rascati, K.L.2    Johnsrud, M.T.3
  • 9
    • 0035668228 scopus 로고    scopus 로고
    • Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: A 1-year follow-up
    • Stempel DA. Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up. Respir Med 2001; 95:992-998.
    • (2001) Respir Med , vol.95 , pp. 992-998
    • Stempel, D.A.1
  • 10
    • 0035144820 scopus 로고    scopus 로고
    • One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma
    • Stempel DA, Meyer JW, Stanford RH, Yancey SW. One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma. J Allergy Clin Immunol 2001; 107:94-98.
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 94-98
    • Stempel, D.A.1    Meyer, J.W.2    Stanford, R.H.3    Yancey, S.W.4
  • 11
    • 0034944210 scopus 로고    scopus 로고
    • Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast
    • Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med 2001; 95:227-234.
    • (2001) Respir Med , vol.95 , pp. 227-234
    • Stempel, D.A.1    Mauskopf, J.2    McLaughlin, T.3    Yazdani, C.4    Stanford, R.H.5
  • 12
    • 0036128508 scopus 로고    scopus 로고
    • Inhaled corticosteroids plus salmeterol or montelukast: Effects on resource utilization and costs
    • Stempel DA, O'Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol 2002; 109:433-439.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 433-439
    • Stempel, D.A.1    O'Donnell, J.C.2    Meyer, J.W.3
  • 13
    • 0034806733 scopus 로고    scopus 로고
    • A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy
    • Bukstein DA, Henk HJ, Luskin AT. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Clin Ther 2001; 23(9):1589-1600.
    • (2001) Clin Ther , vol.23 , Issue.9 , pp. 1589-1600
    • Bukstein, D.A.1    Henk, H.J.2    Luskin, A.T.3
  • 14
    • 0034935739 scopus 로고    scopus 로고
    • Changes in asthma drug therapy-costs for patients receiving chronic montelukast therapy in the UK
    • Price DB, Ben-Joseph RH, Zhang Q. Changes in asthma drug therapy-costs for patients receiving chronic montelukast therapy in the UK. Respir Med 2001; 95(1):83-89.
    • (2001) Respir Med , vol.95 , Issue.1 , pp. 83-89
    • Price, D.B.1    Ben-Joseph, R.H.2    Zhang, Q.3
  • 15
    • 0043137178 scopus 로고    scopus 로고
    • A retrospective descriptive medical claims analysis of increased medical risk in asthma management for patients prescribed montelukast compared to fluticasone propionate
    • abstract 1070
    • Edwards LD, Kral KM, Johnson JR, Lincourt WR. A retrospective descriptive medical claims analysis of increased medical risk in asthma management for patients prescribed montelukast compared to fluticasone propionate [abstract 1070]. J Allergy Clin Immunol 2001; 107(2):S329.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2
    • Edwards, L.D.1    Kral, K.M.2    Johnson, J.R.3    Lincourt, W.R.4
  • 16
    • 0036156334 scopus 로고    scopus 로고
    • Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population
    • Pathak DS, Davis EA, Stanford RH. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population. Pharmacotherapy 2002; 22(2):166-174.
    • (2002) Pharmacotherapy , vol.22 , Issue.2 , pp. 166-174
    • Pathak, D.S.1    Davis, E.A.2    Stanford, R.H.3
  • 17
    • 0036246647 scopus 로고    scopus 로고
    • Asthma: Addressing consistency in results from basic science, clinical trials and observational experience
    • Spahn J, Covar R, Stempel DA. Asthma: addressing consistency in results from basic science, clinical trials and observational experience. J Allergy Clin Immunol 2002; 109:S490-S502.
    • (2002) J Allergy Clin Immunol , vol.109
    • Spahn, J.1    Covar, R.2    Stempel, D.A.3
  • 18
    • 0036256467 scopus 로고    scopus 로고
    • Approaching value in asthma management: The need to intergrate clinical and economic research with the basic science
    • Stempel DA, Kelly HW. Approaching value in asthma management: the need to intergrate clinical and economic research with the basic science. J Allergy Clin Immunol 2002; 109:S503-S510.
    • (2002) J Allergy Clin Immunol , vol.109
    • Stempel, D.A.1    Kelly, H.W.2
  • 19
    • 0032411766 scopus 로고    scopus 로고
    • Treatment of Medicaid patients with asthma: Comparison with treatment guidelines using disease-based drug utilization review methodology
    • Laumann JM, Bjornson DC. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology. Ann Pharmacother 1998; 32(12):1290-1294.
    • (1998) Ann Pharmacother , vol.32 , Issue.12 , pp. 1290-1294
    • Laumann, J.M.1    Bjornson, D.C.2
  • 20
    • 0035078841 scopus 로고    scopus 로고
    • A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use
    • Balkrishnan R, Christensen DB. A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use. J Asthma 2001; 38(1):91-98.
    • (2001) J Asthma , vol.38 , Issue.1 , pp. 91-98
    • Balkrishnan, R.1    Christensen, D.B.2
  • 21
    • 0035186808 scopus 로고    scopus 로고
    • Effect of prescription benefit changes on medical care utilization in a Medicare HMO population
    • Balkrishnan R, Byerly WG, Camacho FT, Shrestha A, Anderson RT. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care 2001; 7(11):1093-1100.
    • (2001) Am J Manag Care , vol.7 , Issue.11 , pp. 1093-1100
    • Balkrishnan, R.1    Byerly, W.G.2    Camacho, F.T.3    Shrestha, A.4    Anderson, R.T.5
  • 22
    • 0034944210 scopus 로고    scopus 로고
    • Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast
    • Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med 2001; 95:227-234.
    • (2001) Respir Med , vol.95 , pp. 227-234
    • Stempel, D.A.1    Mauskopf, J.2    McLaughlin, T.3    Yazdani, C.4    Stanford, R.H.5
  • 24
    • 0033795336 scopus 로고    scopus 로고
    • Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments
    • Balkrishnan R, Christensen DB. Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments. J Asthma 2000; 37(6):511-517.
    • (2000) J Asthma , vol.37 , Issue.6 , pp. 511-517
    • Balkrishnan, R.1    Christensen, D.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.